Impact of Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer Metastatic
- Sponsor
- Care Partners
- Enrollment
- 31
- Locations
- 1
- Primary Endpoint
- Change in Opioid Use for Pain Management
- Last Updated
- 6 years ago
Overview
Brief Summary
Feasibility study to report on the impact of ACCESS of single-fraction radiation therapy on cancer patients with bone metastases enrolled in hospice care.
Detailed Description
Hospice care for terminally ill patients with metastatic cancer improves quality of life, pain control, and potentially also survival when patients are enrolled early.1-3 However, hospice programs are often seen by patients and their caregivers as the last resort after exhaustion of all effective treatment options. The need to revoke active treatment (for all hospice patients with cancer outside of the VA system) discourages hospice enrollment. This study aims to understand and analyze barriers to access specifically for short course palliative radiation therapy in cancer patients enrolled in hospice.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Solid Tumor Malignancies and Multiple Myeloma with Bone Metastases and Associated Bone Pain Enrolled in Hospice
Exclusion Criteria
- •Decisionally-Impaired Subjects, Pregnant Women
Outcomes
Primary Outcomes
Change in Opioid Use for Pain Management
Time Frame: Through study completion, an average of 1 year
Opioid Dosage (mg/day)
Secondary Outcomes
- Improved Quality of Life Measures(During study completion)
- Improved Activities of Daily Living(During study completion)